Trafficking of M(2) muscarinic acetylcholine receptors. 1999

A G Roseberry, and M M Hosey
Department of Molecular Pharmacology, Northwestern University Medical School, Chicago, Illinois 60611, USA.

Internalization is an important mechanism regulating the agonist-dependent responses of G-protein-coupled receptors. The internalization of the M(2) muscarinic cholinergic receptors (mAChR) in HEK293 cells has been demonstrated to occur by an unknown mechanism that is independent of arrestins and dynamin. In this study we examined various aspects of the trafficking of the M(2) mAChR in HEK293 cells to characterize this unknown pathway of internalization. Internalization of the M(2) mAChR was rapid and extensive, but prolonged incubation with agonist did not lead to appreciable down-regulation (a decrease in total receptor number) of the receptors. Recovery of M(2) mAChRs to the cell surface following agonist-mediated internalization was a very slow process that contained protein synthesis-dependent and -independent components. The protein synthesis-dependent component of the recovery of receptors to the cell surface did not appear to reflect a requirement for synthesis of new receptors, as no changes in total receptor number were observed either in the presence or absence of cycloheximide. Phosphorylation of the M(2) mAChR did not appear to influence the rate or extent of the recovery of receptors to the cell surface, as the recovery of a phosphorylation-deficient mutant M(2) mAChR, the N,C(Ala-8) mutant, was similar to the recovery of the wild type M(2) mAChR. Finally, the constitutive, nonagonist-dependent internalization and recycling of the M(2) mAChR was very slow and also contained protein synthesis-dependent and -independent components, suggesting that a similar pathway controls the recovery from agonist-dependent and -independent internalization. Overall, these data demonstrated a variety of previously unappreciated facets involved in the regulation of M(2) mAChRs.

UI MeSH Term Description Entries
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004705 Endocytosis Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis. Endocytoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D018721 Muscarinic Agonists Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate. Cholinergic Agonists, Muscarinic,Cholinergic Agonist, Muscarinic,Cholinergic Muscarinic Agonists,Muscarinic Agonist,Agonist, Muscarinic,Agonist, Muscarinic Cholinergic,Agonists, Cholinergic Muscarinic,Agonists, Muscarinic,Agonists, Muscarinic Cholinergic,Muscarinic Agonists, Cholinergic,Muscarinic Cholinergic Agonist,Muscarinic Cholinergic Agonists

Related Publications

A G Roseberry, and M M Hosey
January 1999, The Journal of pharmacology and experimental therapeutics,
A G Roseberry, and M M Hosey
July 2018, Neuropharmacology,
A G Roseberry, and M M Hosey
July 2008, Pharmacology & therapeutics,
A G Roseberry, and M M Hosey
January 2006, Current pharmaceutical design,
A G Roseberry, and M M Hosey
October 2001, Brain research,
A G Roseberry, and M M Hosey
March 1989, The Journal of pharmacology and experimental therapeutics,
A G Roseberry, and M M Hosey
June 2001, Journal of neurochemistry,
Copied contents to your clipboard!